Therapy
Biotechnology
Health
Exelixis
$21.279876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$21.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.86 (-3.89%) Today
$0.00 (0.00%) As of 5:05 PM EDT after-hours
Why Robinhood?
You can buy or sell Exelixis and other stocks, options, ETFs, and crypto commission-free!
About EXEL
Exelixis, Inc. Common Stock, also called Exelixis, is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. Read More It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in South San Francisco, CA.
Employees
484
Headquarters
Parkway Alameda, California
Founded
1994
Market Cap
6.41B
Price-Earnings Ratio
10.23
Dividend Yield
0.00
Average Volume
1.99M
High Today
$22.25
Low Today
$21.22
Open Price
$22.14
Volume
2.39M
52 Week High
$25.31
52 Week Low
$13.42
Collections
Therapy
Biotechnology
Health
Cancer Prevention
Pharmaceutical
Biopharmaceutical
Medical
Technology
EXEL News
Price Paid on Robinhood
3% Higher
Right Now
52 Week Low
$13.42
Average Price Paid
$20.74
52 Week High
$25.31
Analyst Ratings
71%
of 14 ratings
Buy
71%
Hold
29%
Sell
0%
EXEL Earnings
$0.12
$0.22
$0.31
$0.41
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Jul 31, After Hours